Ann: FY23 Results Presentation, page-6

First 6 Last

Share
Profile

Follow
rubs1973

592 Posts.

42

25/08/23

16:51

Post #: 69554861
Share

Originally posted by timbowls: ↑

So I just had a more detailed read through everything as well as reading through TGP presentation (it's a little unusual but I often find commentary on TOT in here that isn't included in the actual TOT presentations). I'm quite surprised at how bullish the language is and actually get the sense that some kind of transaction could be imminent.

They outright mention a share buyback in the same sentence as disposing of the Home HQ Artamon stake which is interesting.

They also say they have a great opportunity to increase scale, improve investor appetite and provide greater diversification in the current market.

Finally in the TGP presentation (in reference to their strategy for TOT) they say that they will "work with private capital on core investment opportunities".

What I can't figure out is how we are going to accomplish an expansion while sitting at a 35 percent gearing ratio (with a stated goal of this staying between 30 percent and 40 percent) along with paying out the vast majority of the current rent in dividends (which they've stated will remain stable for at least another year). There just doesn't seem to be room to move. Particularly considering there is likely to be at least one further drop in asset values in 6 months time which will lift the existing gearing ratio again.

The only thing I can think of is selling stakes in the two properties that they own outright? That would link up with the "private capital" line and would free up capital for further investment. Again though you'd think we'd have to sell these stakes at a discount to what was paid for them.

I've emailed the company and asked for a zoom call to be scheduled with management so hopefully this happens and I can share the clarification that I get on this forum.

Expand

They probably do a capital raise at these low prices abd tgp ups its stake to 50%

TOT Price at posting: 59.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

AZY

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

There are more pages in this discussion • 21 more messages in this thread...

First 6 Last

Add TOT (ASX) to my watchlist

(20min delay)
Last 36.5¢		Change 0.000(0.00%)		Mkt cap ! $77.52M

Open	High	Low	Value	Volume
37.0¢	37.0¢	36.5¢	$1.019K	2.792K

Buyers (Bids)

No.	Vol.	Price($)
4	157039	36.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.0¢	8863	2

View Market Depth

No.	Vol.	Price($)
4	157039	0.360
6	149015	0.355
4	19359	0.350
1	20000	0.345
2	102323	0.340

Price($)	Vol.	No.
0.370	8863	2
0.375	114646	6
0.380	147508	3
0.385	23990	1
0.395	32000	1

Last trade - 10.09am 10/07/2024 (20 minute delay)

TOT (ASX) Chart

Ann: FY23 Results Presentation, page-6

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

Greentech finds lithium trend across 5.5 km at WA's Kobe South

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FY23 Results Presentation, page-6

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

Greentech finds lithium trend across 5.5 km at WA's Kobe South

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News